Radiofrequency Ablation in Thyroid Nodules
Primary Purpose
Thyroid Nodules
Status
Unknown status
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Radiofrequency ablation of the thyroid nodule
Sponsored by
About this trial
This is an interventional treatment trial for Thyroid Nodules focused on measuring radiofrequency, thyroid, nodule
Eligibility Criteria
Inclusion Criteria:
- the presence of subjective symptoms (foreign body sensation, neck discomfort or pain, compressive symptom) or cosmetic problems;
- a poor surgical candidate or refusal to undergo surgery;
- fine-needle aspiration cytology and US findings that were compatible with a benign nodule;
- anxiety about a malignancy.
Exclusion Criteria:
- a nodule less than 5 mm in size;
- follicular neoplasm or malignancy on fine needle aspiration cytology (FNAC);
- a nodule with the sonographic criteria for a malignancy (taller than wide, marked hypoechoic, microcalcifications, ill-defined margins), although FNAC was a benign result;
- previous radiation or operation history to the head and neck; (5) previous sclerosing therapy.
Sites / Locations
- Bezmialem Vakif University medical FacultyRecruiting
- Bezmialem Vakif UniversityRecruiting
- Bezmialem Vakif UniversityRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
radiofrequency ablation of thyroid nodule
Arm Description
Under ultrasonography the thyroid nodules will be ablated by radiofrequency ablation
Outcomes
Primary Outcome Measures
Shrinkage of the thyroid nodule after radiofrequency ablation
Secondary Outcome Measures
Disappearance of the nodules in follow up
Full Information
NCT ID
NCT01750593
First Posted
October 7, 2012
Last Updated
November 27, 2013
Sponsor
Bezmialem Vakif University
1. Study Identification
Unique Protocol Identification Number
NCT01750593
Brief Title
Radiofrequency Ablation in Thyroid Nodules
Official Title
Efficacy of Radiofrequency Ablation in Thyroid Nodules
Study Type
Interventional
2. Study Status
Record Verification Date
November 2013
Overall Recruitment Status
Unknown status
Study Start Date
April 2013 (undefined)
Primary Completion Date
January 2014 (Anticipated)
Study Completion Date
June 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bezmialem Vakif University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Thyroid nodules are common problems and although > 95% are stated to be benign, they may cause some problems like hyperthyroidism, compression symptoms, and cosmesis associated with their function, size and localization. Especially for these nodules, patients undergo surgery and face up with the problems associated with surgical complications although they are not cancer. In some studies, radiofrequency ablation previously used for intrabdominal tumors like hepatic metastasis...,was stated to be efficient in the treatment of benign thyroid nodules and in some recurrent thyroid cancer cases. Therefore, the investigators decided to use this method in our patients having nodules like previously mentioned and see the efficacy and safety of the technique.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thyroid Nodules
Keywords
radiofrequency, thyroid, nodule
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
radiofrequency ablation of thyroid nodule
Arm Type
Experimental
Arm Description
Under ultrasonography the thyroid nodules will be ablated by radiofrequency ablation
Intervention Type
Procedure
Intervention Name(s)
Radiofrequency ablation of the thyroid nodule
Intervention Description
Under USG control, the nodule will be ablated by radiofrequency with a needle that has an active tip of 1 cm.
Primary Outcome Measure Information:
Title
Shrinkage of the thyroid nodule after radiofrequency ablation
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Disappearance of the nodules in follow up
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
the presence of subjective symptoms (foreign body sensation, neck discomfort or pain, compressive symptom) or cosmetic problems;
a poor surgical candidate or refusal to undergo surgery;
fine-needle aspiration cytology and US findings that were compatible with a benign nodule;
anxiety about a malignancy.
Exclusion Criteria:
a nodule less than 5 mm in size;
follicular neoplasm or malignancy on fine needle aspiration cytology (FNAC);
a nodule with the sonographic criteria for a malignancy (taller than wide, marked hypoechoic, microcalcifications, ill-defined margins), although FNAC was a benign result;
previous radiation or operation history to the head and neck; (5) previous sclerosing therapy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Erhan Aysan, Prof. Dr.
Email
erhanaysan@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Yeliz Ersoy, Assoc.Prof
Email
yelizemineersoy@yahoo.com
Facility Information:
Facility Name
Bezmialem Vakif University medical Faculty
City
Istanbul
ZIP/Postal Code
34308
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Erhan Aysan, Prof. Dr.
Email
erhanaysan@hotmail.com
Facility Name
Bezmialem Vakif University
City
Istanbul
ZIP/Postal Code
34308
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Erhan Aysan, Prof
Phone
902124531700
Ext
4116
Email
erhanaysan@hotmail.com
First Name & Middle Initial & Last Name & Degree
Yeliz Ersoy, Assoc. Prof
Phone
902124531700
Ext
4506
Email
yelizemineersoy@yahoo.com
Facility Name
Bezmialem Vakif University
City
Istanbul
Country
Turkey
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
ERHAN AYSAN, PROF.
Phone
902124531700
Email
yelizemineersoy@yahoo.com
12. IPD Sharing Statement
Learn more about this trial
Radiofrequency Ablation in Thyroid Nodules
We'll reach out to this number within 24 hrs